Observational studyClinical rheumatology2017

Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.

Marie Desplats et al.PubMed ↗Publisher ↗

No numbers read from the abstract.